TNF and inflammatory bowel disease: Several recent studies of adult IBD patients have shown a reduction of the humoral response to the BNT162b2 mRNA vaccine in persons treated with anti-tumor necrosis factor (TNF) α compared with those not receiving anti-TNFα or healthy controls [10,11,12,13].